Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
834 Integrin αvβ8 inhibitor improves immune checkpoint therapy in advanced ovarian cancer model and its activity can be monitored in blood
Compose a Response to This Article
Other responses
No responses have been published for this article.